CIBC World Market’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$318K Sell
8,343
-1,484
-15% -$62.5K ﹤0.01% 1394
2026
Q2
$462K Sell
9,827
-222
-2% -$5.49K ﹤0.01% 1233
2026
Q1
$190K Buy
+10,049
New +$171K ﹤0.01% 1404
2022
Q3
– Sell
-1,215
Closed -$11.7K – 1291
2022
Q2
$12K Buy
1,215
+1
+0.1% +$13 ﹤0.01% 1251
2022
Q1
$20K Buy
1,214
+178
+17% +$3.09K ﹤0.01% 1285
2021
Q4
$21K Buy
1,036
+11
+1% +$351 ﹤0.01% 1309
2021
Q3
$36K Buy
+1,025
New +$44.3K ﹤0.01% 1313

Other funds holding DFTX

CIBC World Market's DFTX Position: Q3 2026 in Review

CIBC World Market reduced its Definium Therapeutics (DFTX) stake by 15% in Q3 2026, selling an estimated $62.5K and leaving 8,343 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1394.

CIBC World Market first reported a position in DFTX in Q3 2021 and has held it in 7 quarters since. The position peaked at $462K in Q2 2026. 349 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • CIBC World Market held 8,343 shares of Definium Therapeutics worth $318K as of Q3 2026.
  • CIBC World Market sold 1,484 Definium Therapeutics shares in Q3 2026, an estimated $62.5K.
  • Definium Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q3 2026, its #1394 holding.
  • CIBC World Market first reported a position in Definium Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • CIBC World Market's Definium Therapeutics position peaked at $462K in Q2 2026.
  • 349 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on CIBC World Market's 13F filing for Q3 2026, filed 10 Nov 2026.